Chronic HCV infection is a global health problem that affects> 184 million people worldwide.
HCV is associated with several hepatic and extrahepatic disorders, including several …

This review discusses the causes, pathogenesis, and clinical management of
membranoproliferative glomerulonephritis, which accounts for 7 to 10% of biopsy-confirmed …

Abstract The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline on the Evaluation and Care of Living Kidney Donors is intended to assist medical …

Renal pathologists and nephrologists met on February 20, 2015 to establish an
etiology/pathogenesis-based system for classification and diagnosis of GN, with a major aim …

The field of HCV therapeutics continues to evolve rapidly and since the World Health
Organization (WHO) issued its first Guidelines for the screening care and treatment of …

During the last decade great advances have been made of water retention and dilutional
hyponatremia in human cirrhosis. Finally, the field of spontaneous infection of concerning …

Many viruses infect humans and most are controlled satisfactorily by the immune system
with limited damage to host tissues. Some viruses, however, do cause overt damage to the …

Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia syndrome
(MCS). The efficacy and safety of all‐oral direct‐acting antiviral (DAA) therapy in HCV …

The hepatitis C virus (HCV) is a small enveloped RNA virus belonging to the family
flaviviridae and genus hepacivirus. The HCV RNA genome is 9,600 nucleotides in length …

The nephrotic syndrome is defined by a urinary protein level exceeding 3.5 g per 1.73 m2 of
body-surface area per day. At the turn of the century, clinicians distinguished a nephritic …